Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)

The mTOR (mammalian target of rapamycin) signal transduction pathway integrates various signals, regulating ribosome biogenesis and protein synthesis as a function of available energy and amino acids, and assuring an appropriate coupling of cellular proliferation with increases in cell size. In addi...

Повний опис

Бібліографічні деталі
Автори:	Campa, D, Hüsing, A, Stein, A, Dostal, L, Boeing, H, Pischon, T, Tjønneland, A, Roswall, N, Overvad, K, Østergaard, J, Rodríguez, L, Sala, N, Sánchez, M, Larrañaga, N, Huerta, J, Barricarte, A, Khaw, K, Wareham, N, Travis, R, Allen, N, Lagiou, P, Trichopoulou, A, Trichopoulos, D, Palli, D, Sieri, S, Tumino, R, Sacerdote, C, Van Kranen, H, Bueno-De-Mesquita, H, Hallmans, G, Johansson, M, Romieu, I, Jenab, M, Cox, D, Siddiq, A, Riboli, E, Canzian, F, Kaaks, R
Формат:	Journal article
Мова:	English
Опубліковано:	Public Library of Science 2011

Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)

Схожі ресурси